Ongoing search for Quality.
Since 1933

THE COMPANY

F.I.R.M.A is a high-profile professional structure

Find out more

OUR PHARMACEUTICAL PRODUCTS

FIRMA has a large portfolio of drugs in various therapeutic areas

Find out more

PHARMACOVIGILANCE

Pharmacovigilance: what does monitoring a pharmaceutical product mean?

Find out more

THE COMPANY

F.I.R.M.A is a high-profile professional structure. ...

OUR DRUGS

FIRMA has a large portfolio of drugs in various therapeutic areas...

PHARMACOVIGILANCE

Pharmacovigilance: what does it mean to monitor drugs?

Therapeutics areas

ANTIBIOTIC THERAPY

Antibiotics have always played an important role in the history and development of F.I.R.M.A, starting from the sulphur drugs which were the first anti-bacterial agents produced in the late 1950s...

Find out more

CARDIOVASCULAR

HYPERTENSION. Arterial hypertension is a condition characterised by the increase in blood pressure values in the arteries...

Find out more

CORTICOSTEROIDS

Corticosteroids, synthetic analogues of the natural steroid hormones produced by the adrenal cortex, are substances which feature an anti-inflammatory and immunosuppressive action and are indicated for various allergies, rheumatic diseases, autoimmune diseases, etc.

Find out more

DERMATOLOGY

Dermatology is the branch of medicine that deals with the diagnosis and treatment of skin diseases and skin appendages.

Find out more

UROLOGY

ERECTILE DYSFUNCTION. Erectile dysfunction is defined as the recurring inability to achieve and/or maintain an erection suitable for successful sexual intercourse.

Find out more

OTHER PRODUCTS

 

Find out more

CONSUMER HEALTHCARE

 

Find out more

Apteni Diagent

From November 15, 2021 FIRMA has suspended production and distribution of APTENI DIAGENT following the Decree issued by AIFA General Director (no. DG/1334/2021) on November 10, 2021 published in the Italian Official Journal No. 272 of Nov. 15, 2021.

Apteni Diagent

From November 15, 2021 FIRMA has suspended production and distribution of APTENI DIAGENT following the Decree issued by AIFA General Director (no. DG/1334/2021) on November 10, 2021 published in the Italian Official Journal No. 272 of Nov. 15, 2021.

Contact us

DO YOU NEED INFORMATIONS?
WE ARE AT YOUR DISPOSAL

Request info

Work with us

OPEN POSITIONS
SEND US YOUR CV

Fill the form